CSafe Global launches real-time shipment visibility platform
Industry customers now have access to 24/7 real-time shipment visibility across the company's entire product portfolio
CSafe Global, an innovation provider of temperature-controlled container solutions for pharmaceuticals transformation has announced the full commercial launch of its real-time shipment visibility platform and technology.
Users of CSafe can now make data-driven decisions to ensure the safe delivery of medicines to patients worldwide.
Available now to CSafe air cargo customers, the company has already started retrofitting active RKN and RAP containers with the new sensors capable of tracking location and condition.
The platform, custom built by Cloudleaf in close collaboration with CSafe operations, provides real-time alerts and notifications directly to customers via email, text or in the platform itself of the following for each shipment: cargo temperature outside set parameters, door open events, ambient temperature change outside set parameters, shock event, tilt event, ambient pressure change outside set parameters, ambient humidity change outside set parameters and route deviation/delay.
The new platform will also benefit customers with its range of other additional features; for example, they will have access to historical shipments, be able to add unlimited platform users and receive GDP-compliant standard shipment reports.
Describing the culmination of the 2-year project, Patrick Schafer, CSafe CEO, said the new platform delivers "so much more than just basic functionality". Instead, it is a "system that is fit for our customers’ needs today and agile enough to easily accommodate enhancements and new innovations well into the future," he added.
The work is not yet over. Tom Weir, CSafe COO, said the company will be retrofitting the remainder of the active container fleet throughout Q1 before moving on to enhancements. The company also plans to bring its cell & gene customers onto the platform and implement the system for VIP Parcel containers and customers.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance